AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Open Access
- 16 December 2022
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 108, 255-268
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Economía y Competitividad (RTI2018-098830-B-I00)
- Instituto de Salud Carlos III (PI20/00345, RD21/0017/0031)
- Xunta de Galicia Consellería de Educacion e Ordenación Universitaria (ED431G/05)
- Ministerio de Economía y Competitividad
- Consejería de Salud y Familias, Junta de Andalucía
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Federación Española de Enfermedades Raras
This publication has 91 references indexed in Scilit:
- Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activationInternational Journal of Interferon, Cytokine and Mediator Research, 2011
- The renin angiotensin system and the metabolic syndromePhysiology & Behavior, 2010
- Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseasesArthritis Research & Therapy, 2010
- Autoantibody-Mediated Angiotensin Receptor Activation Contributes to Preeclampsia Through Tumor Necrosis Factor-α SignalingHypertension, 2010
- LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytesInternational Journal of Obesity, 2009
- Oxysterols and neurodegenerative diseasesMolecular Aspects of Medicine, 2009
- Angiotensin II Modulates BBB Permeability via Activation of the AT1Receptor in Brain Endothelial CellsJournal of Cerebral Blood Flow & Metabolism, 2009
- Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant miceNature Medicine, 2008
- Angiotensin II protects against α-synuclein toxicity and reduces protein aggregation in vitroBiochemical and Biophysical Research Communications, 2007
- Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2)Journal of Biological Chemistry, 2005